Navigation Links
Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
Date:7/3/2009

SAN FRANCISCO, July 3 /PRNewswire-USNewswire/ -- Tomorrow, Corey Reich, an ALS patient from Piedmont, California, will attend both the San Francisco Giants and Los Angeles Angels of Anaheim baseball games this July 4th as a representative of the ALS Therapy Development Institute (ALS TDI). Corey will attend both baseball games to raise awareness of amyotrophic lateral scleroses (ALS, Lou Gehrig's disease) a neurodegenerative disease of which he suffers and for which there is no known cause or cure.

"My hope is that my presence at both games will help to put a new face on this disease by providing a personal connection to ALS," said Corey. "Although it is an orphan disease, I hope to bring larger public awareness and increased funding for research, which could speed up the discovery of therapies for people like me living with ALS."

Corey was diagnosed in July of 2007, but he had shown symptoms for several years prior. After his diagnosis, he returned to Middlebury College and graduated with honors in May of 2008. He currently is the assistant tennis coach for the Piedmont High School Men's and Women's Tennis Teams. Corey and his family have supported ALS TDI for the past 18 months and have raised more than $700,000 in that time. Fundraising events organized by "Corey's Crusaders" have included a cocktail party in the Vancouver, Washington area, a running race in Boise, a bake sale in Oakland, a dinner and dance also in Oakland, and another dinner and dance in Bronxville, New York. ALS TDI, based in Cambridge, Massachusetts, is a 501c3 nonprofit charitable organization and the largest research center dedicated solely to the development of therapeutics for this debilitating disease.

Corey's attendance at the Giants' and Angels' games coincides with the culmination of Major League Baseball's "4ALS Awareness" campaign. MLB is working with four leading organizations -- The ALS Association, AL
'/>"/>

SOURCE ALS Therapy Development Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Encision Enters Into Sales Representation Agreement With Caldera Medical
2. Air Transport Association Applauds House of Representatives on Decision to Withhold Biometric Collection Funding
3. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
4. CMR Institute: Education Key to Physician/Representative Relationship
5. Microfluidic Systems to Show Automated Biological Agent Detection Technology to U.S. House of Representatives
6. 125 Indevus Sales Representatives to Provide Community Service in New Orleans for Jericho Road Episcopal Housing Initiative
7. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer
8. ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
9. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
10. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
11. Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...wswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC )...rd quarter ended September 30, 2009. GenVec report...r the three months ended September 30, 2009 compar... in the comparable quarter of 2008. For the nine m...was $14.1 million ($0.15 per share), compared to a...
(Date:11/5/2009)...vember 5, 2009 at 4:30 p.m. Eastern Time , BO...ll/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex"... unaudited financial results for the third quarter...ewed the Company,s highlights for the third quarte...s reflect the operations of OncoGenex Technologies...
(Date:11/5/2009)... Senomyx, Inc. (Nasdaq: ...ste receptor-based technologies to discover novel ...redient supply industries, today provided a corpor...third quarter ended September 30, 2009. Revenues ...ompared to $4.0 million for the third quarter of 2...
(Date:11/5/2009)...ry and vision correction experts listed in the Tru...ed at the recently concluded American Academy of O...cisco, California. Dr. Stephen Brint, MD, Dr. Fred...Dr. Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr....Edward Manche, MD, and Dr. Parag Majmudar, MD, all...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...irstCall/ - Quest PharmaTech Inc.,("Quest" or the ...llaborative research agreement with the BC Cancer ...py for the treatment of lung cancer. The,potential...y product,SL052, with various immunotherapeutic ag... (PDT) can augment the therapeutic effects of,immu...
...onfirmed today that,entities affiliated with him h...o nominate three persons at Biogen,s forthcoming 2...ectors of Biogen. Biogen currently,has a staggered...ectorships,up for election this year., Mr. Icahn ...believe,that Biogen,s recent purported attempt to ...
...ura Therapeutics Inc., an,early stage biotechnolog...cently completed a successful Investigational New ...dministration (FDA). The IND enables Velcura to,pr...s lead compound,VEL-0230., VEL-0230 is a new chem...at it both stimulates bone formation and inhibits ...
Other Biology Technology:Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 2Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer 3Icahn Confirms Intention to Nominate Three Directors at Biogen 2Icahn Confirms Intention to Nominate Three Directors at Biogen 3Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA 2
(Date:11/3/2009)... MADISON, WI, NOVEMBER 4, 2009 -- The world,s g...y among grape variety, human input, and something ...e vineyard site, soil, and climate. , Experts ...nce in a symposium on Wednesday, Nov. 4 in Pittsbu...ll be presented in two parts at the 2009 Annual Me...
(Date:11/3/2009)... The white shark may be the ultimate loner of the...trek, but a team of researchers has discovered tha...tern of migration that over tens of thousands of y...Ocean have separated themselves into a population ...world. , "White sharks are a large, highly mobil...
(Date:11/3/2009)... , LAKE ALFRED, FLLaser labeling of fruit and v... low-energy carbon dioxide laser beam is used to l...iminating the need for common sticker-type labels....iety of fruits and vegetables and is being used in.... It has been been approved in Asia, South Africa,...
Breaking Biology News(10 mins):Great wines come from great soils 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Laser etching safe alternative for labeling grapefruit 2The Leukemia 26 Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense 49377 1The Leukemia 26 Lymphoma Society Calls for Blood Cancer Research Program at the Department of Defense 49377 2First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 1First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 2First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 3First World Congress on Positive Psychology Kicks Off Today With Talks by Two of the Worlds Most Renowned Psychologists Martin Seligman and Philip Zi 49373 4Studies Highlight A Revolutionary New Method of Treating Post Operative Bruising 49369 1Studies Highlight A Revolutionary New Method of Treating Post Operative Bruising 49369 2Studies Highlight A Revolutionary New Method of Treating Post Operative Bruising 49369 3
...s have devised a tool to help understand and predi... 70,000 nucleosomes in yeast. Nucleosomes wrap DNA...itical indicators and regulators of a cells state....sor with the Banting and Best Department of Medica...he team created a complete, three-dimensional map ...
...gns of the oceans matters increasingly to the well...ip of international scientists urging support to c... years. , The Partnership for Observation of the ...ng and pollution are among profound concerns that ... a well-informed, timely and cost-effective way. ,...
...ck there. Farmers may find phytochemicals to be th...n the bucket that cashes in on the tug-o-war betwe...h by the Texas Agricultural Experiment Station. , ...tables in the farm patch increases disease-prevent...ers may one day pay a premium, scientists say. , ...
Other Biology News:Human safety, prosperity depend on better ocean observing system: Scientists 2Human safety, prosperity depend on better ocean observing system: Scientists 3Human safety, prosperity depend on better ocean observing system: Scientists 4Human safety, prosperity depend on better ocean observing system: Scientists 5Human safety, prosperity depend on better ocean observing system: Scientists 6Human safety, prosperity depend on better ocean observing system: Scientists 7Human safety, prosperity depend on better ocean observing system: Scientists 8Old McDonald had a phytochemical 2Old McDonald had a phytochemical 3
...Protein DetectorTM Microarray Dot Blot Kits overco...uracy and quantitation over a wide range in low-de...tection. They are ideal for performing reverse-ph...amples for the presence of low abundant antigens. ...
...Convenient, easy-to-use kits for arraying proteins...tion using common lab equipment. DiscoverLight Pro...ur protein, cell lysate or antibody in a low-densi...ed nitrocellulose membranes with a 384-grid templa...
Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.
...StabilZyme AP Conjugate Stabilizer is an aqueous s...d other non-toxic stabilizing chemicals in a MES b...6.5. This product contains a combination of 0.02%...s a preservative. StabilZyme AP Conjugate Stabili...
Biology Products: